Detalhe da pesquisa
1.
Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity.
Immunity
; 54(10): 2354-2371.e8, 2021 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614413
2.
Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial.
Neuro Oncol
; 26(2): 348-361, 2024 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715730
3.
Antigen-Specific Antitumor Responses Induced by OX40 Agonist Are Enhanced by the IDO Inhibitor Indoximod.
Cancer Immunol Res
; 6(2): 201-208, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29305519
4.
Differential PI3Kδ Signaling in CD4+ T-cell Subsets Enables Selective Targeting of T Regulatory Cells to Enhance Cancer Immunotherapy.
Cancer Res
; 77(8): 1892-1904, 2017 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28108509
5.
Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy.
J Immunother Cancer
; 5(1): 64, 2017 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28807056
6.
Enhanced Therapeutic Efficacy and Memory of Tumor-Specific CD8 T Cells by Ex Vivo PI3K-δ Inhibition.
Cancer Res
; 77(15): 4135-4145, 2017 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28615225
7.
Transcriptomes and shRNA suppressors in a TP53 allele-specific model of early-onset colon cancer in African Americans.
Mol Cancer Res
; 12(7): 1029-41, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24743655